$48.5 Million is the total value of Parian Global Management LP's 12 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 100.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
RNLX | Exit | RENALYTIX PLCput | $0 | – | -5,600 | -100.0% | -0.07% | – |
RNLX | Exit | RENALYTIX PLCcall | $0 | – | -15,000 | -100.0% | -0.19% | – |
XRAY | Exit | DENTSPLY SIRONA INCcall | $0 | – | -7,500 | -100.0% | -0.34% | – |
TKNO | Exit | ALPHA TEKNOVA INC | $0 | – | -38,069 | -100.0% | -0.63% | – |
QDEL | Exit | QUIDEL CORP | $0 | – | -6,000 | -100.0% | -0.65% | – |
STIM | Exit | NEURONETICS INCcall | $0 | – | -200,000 | -100.0% | -0.72% | – |
Exit | ISOPLEXIS CORP | $0 | – | -122,330 | -100.0% | -0.90% | – | |
CSTL | Exit | CASTLE BIOSCIENCES INC | $0 | – | -29,498 | -100.0% | -1.02% | – |
VAPO | Exit | VAPOTHERM INCcall | $0 | – | -75,000 | -100.0% | -1.25% | – |
LHDX | Exit | LUCIRA HEALTH INC | $0 | – | -183,804 | -100.0% | -1.27% | – |
PODD | Exit | INSULET CORP | $0 | – | -6,300 | -100.0% | -1.35% | – |
BLFS | Exit | BIOLIFE SOLUTIONS INC | $0 | – | -55,100 | -100.0% | -1.65% | – |
XRAY | Exit | DENTSPLY SIRONA INC | $0 | – | -37,578 | -100.0% | -1.68% | – |
BDSX | Exit | BIODESIX INC | $0 | – | -396,228 | -100.0% | -1.68% | – |
BRKS | Exit | AZENTA INC | $0 | – | -20,500 | -100.0% | -1.70% | – |
BLI | Exit | BERKELEY LTS INCcall | $0 | – | -120,000 | -100.0% | -1.75% | – |
ANGO | Exit | ANGIODYNAMICS INC | $0 | – | -82,500 | -100.0% | -1.83% | – |
USIO | Exit | USIO INC | $0 | – | -551,013 | -100.0% | -1.93% | – |
SGRY | Exit | SURGERY PARTNERS INC | $0 | – | -45,797 | -100.0% | -1.96% | – |
QTRX | Exit | QUANTERIX CORP | $0 | – | -65,010 | -100.0% | -2.21% | – |
IRTC | Exit | IRHYTHM TECHNOLOGIES INCcall | $0 | – | -23,900 | -100.0% | -2.26% | – |
PFE | Exit | PFIZER INCput | $0 | – | -100,000 | -100.0% | -4.74% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-16
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
VAPOTHERM INC | 12 | Q3 2022 | 38.0% |
RENALYTIX PLC | 9 | Q3 2022 | 9.8% |
ALPHATEC HLDGS INC | 8 | Q3 2022 | 7.6% |
EVENTBRITE INC | 8 | Q3 2021 | 5.9% |
TPI COMPOSITES INC | 7 | Q2 2020 | 14.1% |
NEURONETICS INC | 7 | Q3 2022 | 10.5% |
BERKELEY LTS INC | 7 | Q3 2022 | 8.7% |
AXONICS MODULATION TECHNOLOG | 7 | Q2 2021 | 5.7% |
CVRX INC | 6 | Q3 2022 | 14.6% |
STEREOTAXIS INC | 6 | Q3 2022 | 6.1% |
View Parian Global Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Neuronetics, Inc. | February 13, 2023 | 760,410 | 2.8% |
ARTELO BIOSCIENCES, INC.Sold out | February 09, 2022 | 0 | 0.0% |
Humacyte, Inc.Sold out | February 09, 2022 | 0 | 0.0% |
ACACIA RESEARCH CORPSold out | June 24, 2021 | 0 | 0.0% |
Alpha Healthcare Acquisition Corp. | March 01, 2021 | 844,734 | 8.2% |
Blue Apron Holdings, Inc. | February 28, 2020 | 348,900 | 4.3% |
View Parian Global Management LP's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
SC 13G/A | 2024-02-14 |
SC 13G/A | 2023-02-13 |
SC 13G/A | 2023-02-13 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-15 |
13F-HR | 2022-05-16 |
13F-HR | 2022-02-14 |
SC 13G/A | 2022-02-09 |
SC 13G/A | 2022-02-09 |
SC 13G/A | 2022-02-09 |
View Parian Global Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.